Send Enquiry

PRIMA
Tablets
Packaging and packing Type
Alu Alu | 10x10
MRP :
₹85
PTR :
₹64.76
PTS :
₹58.29
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Respiratory PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Dazivib 5 is an oral tablet from Vibcare Pharma's Prima division. Each tablet contains Desloratadine 5 mg. It belongs to the anti-allergic and anti-histamine class of medicines, and is supplied as 10x10 (Alu Alu).
Desloratadine, the single ingredient in this tablet, is a long-acting antihistamine. It blocks the action of histamine at the H1 receptor in the body. When histamine is held back in this way, the allergic response that causes sneezing, a runny or blocked nose, watery eyes, itching and hives is eased. It is a selective H1-receptor antagonist with tricyclic structure.
Dazivib 5 is used for relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis and of perennial allergic rhinitis, and for symptomatic relief of itching, with a reduction in the number and size of hives, in chronic idiopathic urticaria, in patients 12 years of age and older. If a hypersensitivity reaction such as rash, itching, swelling or difficulty in breathing occurs after taking it, the medicine must be stopped at once and a doctor consulted for an alternative treatment. Use only on a doctor's prescription.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
For distributors and medical representatives
Dazivib 5 Tablet is part of Vibcare Pharma's respiratory range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Dazivib 5 tablets contain Desloratadine 5 mg for relief of allergic rhinitis symptoms and chronic idiopathic urticaria. Main uses: relief of nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older; relief of nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older; symptomatic relief of itching (pruritus) in chronic idiopathic urticaria in patients 12 years of age and older; reduction in the number of hives in chronic idiopathic urticaria; reduction in the size of hives in chronic idiopathic urticaria.
Common side effects of Dazivib 5 Tablet include pharyngitis (sore throat); dry mouth; myalgia (muscle pain); fatigue; somnolence (drowsiness); dysmenorrhea (painful menstrual periods). Get medical help at once if you notice hypersensitivity reactions such as rash, pruritus, urticaria, swelling (edema) and difficulty in breathing (dyspnea); anaphylaxis (severe allergic reaction).
Each Dazivib 5 tablet contains Desloratadine 5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Dazivib 5 Tablet only as your doctor advises.
The MRP of Dazivib 5 Tablet is ₹85 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹64.76 and the PTS is ₹58.29.
Each Dazivib 5 tablet contains Desloratadine 5 mg. It comes in a pack of 10x10 (Alu Alu).
Desloratadine, the single ingredient in this tablet, is a long-acting antihistamine. It blocks the action of histamine at the H1 receptor in the body. When histamine is held back in this way, the allergic response that causes sneezing, a runny or blocked nose, watery eyes, itching and hives is eased. It is a selective H1-receptor antagonist with tricyclic structure.
Must not be used by patients who are hypersensitive to desloratadine, to any ingredient of the tablet, or to loratadine. Must not be used if a hypersensitivity reaction such as rash, swelling or difficulty in breathing occurs; the medicine should be stopped at once and an alternative treatment considered.
Dazivib 5 Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner